Dec. 13 at 2:10 PM
$CLDI guess where CLDI and Eric Poma fall in the 76 page document, also included is evidence from his time at Molecular Templates.
“This action arises from Defendants’ orchestrated scheme to artificially inflate the stock price of a thinly traded biotechnology penny stock through undisclosed paid promotions, false and misleading public statements, and deceptive investor-relations campaigns.
Defendants knowingly paid promoters and third-party marketers to disseminate bullish and fraudulent claims about the Company’s purported scientific breakthroughs and imminent commercial success, while concealing the Company’s lack of viable products, meaningful revenue, and legitimate clinical progress.”
